Drug Trial Radar · NCT00671502
A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back
Last checked: Nov 20, 2026Latest source record: Nov 9, 2011 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
840
Actual
Start
Apr 2008
Primary completion
Feb 2009
Study completion Feb 2009
Sponsor
- Lead sponsor
- Meda PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- May 5, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine if two sustained released formulations of carisoprodol are more effective than placebo.
Conditions
- Lower Back Pain
Interventions
Carisoprodol SRDrug
700 mg twice daily
Carisoprodol SRDrug
500 mg twice daily
PlaceboDrug
Placebo tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Subject Rating of Pain on a 100-point Visual Analog Scale (VAS)Time frame: up to 14 days
Locations
68 sites in 1 country. Site status is shown where the registry gives one.
MedSearch, LLC
Birmingham, Alabama
Genesis Clinical Research Corporation
Huntsville, Alabama
Vaughn H. Mancha, Jr., PC Family Practice
Montgomery, Alabama
Anasazi Internal Medicine PC
Phoenix, Arizona
Heritage Physician Group
Hot Springs, Arkansas
OrthoArkansas
Little Rock, Arkansas
Family Practice Clinic
North Little Rock, Arkansas
Quality of Life Medical Center, LLC
Hawaiian Gardens, California
Trinity Health and Wellness
Roseville, California
San Diego Sports Medicine & Family Health Center
San Diego, California
Quality Care Medical Center, Inc.
Vista, California
Anthony Roselli, MD
Avon, Connecticut
Clinical Research of South Florida
Coral Gables, Florida
Southeastern Integrated Medical, PL dba Florida Medical Research Institute
Gainesville, Florida
South Florida Clinical Research Center
Hollywood, Florida
FPA Clinical Research
Kissimmee, Florida
Genesis Research International
Longwood, Florida
Well Pharma Medical Research Corporation
Miami, Florida
International Research Associates, LLC
Miami, Florida
Tukoi Clinical Research
Miami, Florida
Renstar Medical Research
Ocala, Florida
University Clinical Research, Inc.
Pembroke Pines, Florida
Sunrise Medical Research #501
Plantation, Florida
Southwest Florida Clinical Research Center
Tampa, Florida
Palm Beach Research Center
West Palm Beach, Florida
Perimeter Institute for Clinical Research, Inc.
Atlanta, Georgia
Sunset Medical Research
Sunset, Louisiana
Clinical Pharmacology Study Group
Worcester, Massachusetts
Northern Pines Health Center
Buckley, Michigan
KMED Research
Clair Shores, Michigan
Harris & Associates, P.C.
Detroit, Michigan
Valley Medical Center
Flint, Michigan
Westside Family Medical Center, P.C.
Kalamazoo, Michigan
Kansas City University of Medicine and BioSciences Dybedal Building
Kansas City, Missouri
Comprehensive Clinical Research
Berlin, New Jersey
South Jersey Medical Associations, PA
Blackwood, New Jersey
Care Center of Family Practice & Pediatrics of Hamilton
Hamilton, New Jersey
Partners in Primary Care
Voorhees Township, New Jersey
Albuquerque Clinical Trials, Inc.
Albuquerque, New Mexico
Metrolina Medical Research
Charlotte, North Carolina
Showing 40 of 68 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.